Will Penumbra (PEN) Beat Estimates Again in Its Next Earnings Report?

Medical device maker Penumbra (PEN) has a strong history of exceeding earnings estimates, with an average surprise of 16.18% over its last two reports. Analysts anticipate this trend may continue, as the company currently holds a positive Zacks Earnings ESP of +1.28% and a Zacks Rank #3 (Hold). This combination historically indicates a nearly 70% chance of an earnings beat, suggesting Penumbra is well-positioned for an upside surprise in its upcoming report scheduled for July 29, 2025.

Analysis

Penumbra, Inc. (PEN) demonstrates a notable pattern of exceeding Wall Street expectations, with an average earnings surprise of 16.18% over its last two fiscal quarters. The medical device maker's most recent report featured earnings of $0.83 per share, significantly outperforming the Zacks Consensus Estimate of $0.66 by 25.76%. This follows a previous quarter where the company delivered a 6.59% surprise. Current forward-looking indicators suggest this trend may persist. The company holds a positive Zacks Earnings ESP (Expected Surprise Prediction) of +1.28%, signaling that recent analyst revisions are trending more bullish than the consensus. When combined with its Zacks Rank #3 (Hold), historical data suggests there is a nearly 70% probability of another earnings beat in its upcoming report, which is scheduled for July 29, 2025. These quantitative signals point towards a high likelihood of a positive short-term catalyst for the stock.

Key Decisions for Investors

• Given the positive Earnings ESP of +1.28% and a strong history of beats, investors may anticipate a positive earnings surprise on July 29, 2025, which could serve as a short-term catalyst for the stock.
• Despite the bullish earnings indicators, the stock's Zacks Rank #3 (Hold) warrants consideration, suggesting that investors should weigh the high probability of a beat against potentially neutral underlying fundamentals.
• Traders focused on earnings events might view the statistical probability of a beat as a basis for a tactical pre-earnings position, while long-term investors should monitor the actual results and management guidance to validate the company's growth trajectory.